ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

FDA Officials Discuss Extrapolation & Confusion Around Pediatric Therapies

Thomas R. Collins  |  December 3, 2024

A session at ACR Convergence 2024 addressed several recent drug approvals in pediatric rheumatology and a safety update for IL-1/IL-6 inhibitors.

Filed under:ACR ConvergenceDrug UpdatesPediatric Conditions Tagged with:ACR Convergence 2024Biosimilarsdrug approvalsinterchangeabilityPediatric RheumatologyU.S. Food and Drug Administration (FDA)

Toward Personalized Medicine in Pediatric Lupus

Samantha C. Shapiro, MD  |  November 26, 2024

At this ACR Convergence 2024 session, discussion centered on novel techniques that offer hope for developing personalized therapies for pediatric SLE.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024ACR Convergence 2024 SLE

New ACR President Carol Langford, MD, MHS, Has Optimistic Outlook for Future of Rheumatology

Leslie Mertz, PhD  |  November 23, 2024

“At my very first annual meeting of the ACR, I saw how the ACR brought the whole rheumatology community together, and I knew right away that it was an organization that I wanted to be a part of,” Dr. Langford says. In late November, she became the 88th president of the ACR and looks forward to continuing its focus on education, research and building community.

Filed under:American College of RheumatologyPresident's PerspectiveProfiles Tagged with:ACR presidentLeadership

ADOBE STOCK | Feodora

The Great Pediatric Debate 2024: Cessation or Continuation of Biologics in sJIA Lung Disease?

Ruth Jessen Hickman, MD  |  November 23, 2024

Washington D.C.—At a Sunday, Nov. 17, Pediatrics Great Debate session of ACR Convergence, speakers argued whether patients with systemic juvenile idiopathic arthritis (sJIA) should continue their interleukin (IL) 1/IL-6 biologics if lung disease is suspected. Randy Q. Cron, MD, PhD, the director of the Division of Pediatric Rheumatology at the University of Alabama at Birmingham,…

Filed under:ACR ConvergenceConditionsPediatric Conditions Tagged with:ACR Convergence 2024sJIAsJIA-associated lung disease

The Who, What & Where of Rheumatology

Mary Beth Nierengarten  |  November 22, 2024

In the Medical Education Year in Review session at ACR Convergence 2024, David Leverenz, MD, MEd, discussed the current make-up of rheumatology, how competency is measured and how to help rheumatology fellows thrive.

Filed under:ACR ConvergenceCareerCareer DevelopmentEducation & TrainingMeeting Reports Tagged with:ACR Convergence 2024competency based medical education (CBME)DiversityEducationmedical educationTrainingWorkforce

Tackling the Rheumatology Workforce Shortage

Keri Losavio  |  November 17, 2024

WASHINGTON, D.C.—The workforce shortage in rheumatology is a looming crisis that demands immediate attention. The ACR’s 2015 Workforce Study projected that by 2030, the supply of adult rheumatologists would dwindle by 31%, in contrast to the increase in demand by close to 138%.1 The situation is even worse for pediatric rheumatology and in rural and…

Filed under:ACR ConvergenceCareerGuidanceMeeting ReportsWorkforce Tagged with:ACR Convergence 2024Workforceworkforce shortage

Can Primary Care Physicians Help Rheumatology’s Workforce Shortages?

Ruth Jessen Hickman, MD  |  November 11, 2024

In an effort to ameliorate serious rheumatology provider shortages, the ACR Workforce Solutions Committee has developed a new resource for primary care providers who treat patients with rheumatic conditions.

Filed under:Practice SupportWorkforce Tagged with:Primary Care Physicians

My Rheumatology Research Workshop 2024 Experience

Ioannis Koulas, MD, MS  |  October 7, 2024

The 2024 Rheumatology Research Workshop facilitated educational and relationship-building experiences for early-career and established rheumatology professionals alike. 

Filed under:CareerCareer DevelopmentMeeting Reports Tagged with:ACR Rheumatology Research WorkshopRheumatology Research FoundationRheumatology Research Workshop

With an Aging State Population, California Rheumatology Association Prepares to Increase Its Rheumatology Workforce

Linda Childers  |  October 6, 2024

The organization is supporting multiple bills and initiatives to protect and expand rheumatology care in the state.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:California Rheumatology Alliancestate society

A Half-Century of Rheumatology

Vanessa Caceres  |  September 11, 2024

Celebrating its long history, the Division of Rheumatology & Immunology at Medical University of South Carolina has made strides in scleroderma, lupus and more.

Filed under:CareerMeeting Reports Tagged with:HistoryMedical University of South CarolinaSouth Carolina

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 96
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences